Table of Content:
- Introduction
- Definition of Colorectal Cancer Market
- Scope of the Report
- Methodology
- Executive Summary
- Market Overview
- Market Definition and Segmentation
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Porter's Five Forces Analysis
- PESTEL Analysis
- Colorectal Cancer Market, By Modality
- Diagnosis Type
- Therapy Type
- Imaging Type
- Colorectal Cancer Market, By End User
- Hospitals and Diagnostic
- Research Laboratories
- Colorectal Cancer Market, By Geography
- North America
- United States
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- United Arab Emirates
- South Africa
- Rest of Middle East & Africa
- North America
- Competitive Landscape
- Company Profiles
- Amgen Inc.
- Company Overview
- Product Portfolio and Description
- Key Highlights
- Financial Overview
- Bruker Corporation
- Epigenomics AG
- Clinical Genomics Technologies Pty Ltd.
- VolitionRx Limited
- Novigenix SA
- F. Hoffmann-La Roche AG
- Abbott
- EDP Biotech
- Quest Diagnostics
- Amgen Inc.
- Conclusion and Future Outlook
- Appendix
- Research Methodology
- About the Pharmanucleus
- Disclaimer